Literature DB >> 19258957

Pregnancy outcomes using assisted reproductive technology after fertility-preserving therapy in patients with endometrial adenocarcinoma or atypical complex hyperplasia.

Aera R Han1, Yong-Soon Kwon, D Y Kim, J H Kim, Y M Kim, Y T Kim, J H Nam.   

Abstract

OBJECTIVES: To evaluate the outcomes of pregnancy in young women (<40 years old) with early endometrial cancer or atypical complex hyperplasia who were treated by conservative management followed by assisted reproductive technology (ART).
MATERIALS AND METHODS: Medical charts of 11 patients treated from January 1997 to October 2007 at Asan Medical Center were retrospectively reviewed. These patients had all been treated with progestin and serial dilatation and curettage as primary fertility-preserving therapies.
RESULTS: After pathological remission of disease, 10 patients tried to become pregnant by ART, 4 by in vitro fertilization and embryo transfer, and 6 by controlled ovarian hyperstimulation, with or without intrauterine insemination. Eight women had intrauterine pregnancies, and 6 patients had live births. Patients have been followed up for 9 to 51 months (mean, 21 months) after delivery, with no evidence of tumor recurrence.
CONCLUSIONS: Fertility-preserving therapy followed by ART can be a good option in well-selected patients with early endometrial cancer who want to become pregnant.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19258957     DOI: 10.1111/IGC.0b013e31819960ba

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  10 in total

1.  Current status in the management of uterine corpus cancer in Korea.

Authors:  Nan-Hee Jeong; Jong-Min Lee; Seon-Kyung Lee
Journal:  J Gynecol Oncol       Date:  2010-09-28       Impact factor: 4.401

2.  Analysis of IVF/ICSI outcomes in infertile women with early-stage endometrial cancer and atypical endometrial hyperplasia after conservative treatment.

Authors:  Yaxing Guo; Xuan Zong; Hongzhen Li; Jie Qiao
Journal:  J Assist Reprod Genet       Date:  2022-06-01       Impact factor: 3.357

Review 3.  Fertility sparing surgery for stage IA type I and G2 endometrial cancer in reproductive-aged patients: evidence-based approach and future perspectives.

Authors:  Salvatore Giovanni Vitale; Diego Rossetti; Alessandro Tropea; Antonio Biondi; Antonio Simone Laganà
Journal:  Updates Surg       Date:  2017-02-10

4.  Experiences in fertility preservation: lessons learned to ensure that fertility and reproductive autonomy remain options for cancer survivors.

Authors:  Nicole Noyes; Katherine Melzer; Sarah Druckenmiller; M Elizabeth Fino; Meghan Smith; Jaime M Knopman
Journal:  J Assist Reprod Genet       Date:  2013-08-13       Impact factor: 3.412

Review 5.  Preserving fertility in young patients with endometrial cancer: current perspectives.

Authors:  Eleftheria Kalogera; Sean C Dowdy; Jamie N Bakkum-Gamez
Journal:  Int J Womens Health       Date:  2014-07-29

Review 6.  Comparison among fertility-sparing therapies for well differentiated early-stage endometrial carcinoma and complex atypical hyperplasia.

Authors:  Qing Zhang; Gonghua Qi; Margaux J Kanis; Ruifen Dong; Baoxia Cui; Xingsheng Yang; Beihua Kong
Journal:  Oncotarget       Date:  2017-05-03

7.  Weight control is vital for patients with early-stage endometrial cancer or complex atypical hyperplasia who have received progestin therapy to spare fertility: a systematic review and meta-analysis.

Authors:  Miaomiao Li; Tao Guo; Ran Cui; Ying Feng; Huimin Bai; Zhenyu Zhang
Journal:  Cancer Manag Res       Date:  2019-05-06       Impact factor: 3.602

8.  Factors affecting pregnancy outcomes in young women treated with fertility-preserving therapy for well-differentiated endometrial cancer or atypical endometrial hyperplasia.

Authors:  Osamu Inoue; Toshio Hamatani; Nobuyuki Susumu; Wataru Yamagami; Seiji Ogawa; Takashi Takemoto; Akira Hirasawa; Kouji Banno; Naoaki Kuji; Mamoru Tanaka; Daisuke Aoki
Journal:  Reprod Biol Endocrinol       Date:  2016-01-15       Impact factor: 5.211

9.  Fertility-sparing treatment for intramucous, moderately differentiated, endometrioid endometrial cancer: a Gynecologic Cancer Inter-Group (GCIG) study.

Authors:  Francesca Falcone; Umberto Leone Roberti Maggiore; Violante Di Donato; Anna Myriam Perrone; Luigi Frigerio; Giuseppe Bifulco; Stephan Polterauer; Paolo Casadio; Gennaro Cormio; Valeria Masciullo; Mario Malzoni; Stefano Greggi
Journal:  J Gynecol Oncol       Date:  2020-09       Impact factor: 4.401

10.  Analysis of pregnancy-associated factors after fertility-sparing therapy in young women with early stage endometrial cancer or atypical endometrial hyperplasia.

Authors:  Yuan Fan; Xingchen Li; Jiaqi Wang; Yiqin Wang; Li Tian; Jianliu Wang
Journal:  Reprod Biol Endocrinol       Date:  2021-08-03       Impact factor: 5.211

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.